HAL vs SRNE · P/E 9.3, $19.05B cap vs $385.9K cap
Halliburton Company (HAL) versus Sorrento Therape (SRNE) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
HAL does not have a complete income-statement cache yet.
SRNE does not have a complete income-statement cache yet.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. SRNE currently screens at market cap $385.9K.
Not investment advice. Open the HAL and SRNE stock pages for the full models.
Not investment advice.